Table 5.
Molecular Mechanism of hucMSCs-EVs in Treating Different Diseases in the Respiratory System
| HucMSCs-EVs Cargo | Target/Signaling | Conditions/Diseases | Actiona | Reference |
|---|---|---|---|---|
| None reported | NF-κB | COVID-19 | Systemic inflammation↓ | [22] |
| miR-126, miR-30b | None reported | COVID-19 | Pulmonary fibrosis↓ | [213] |
| miR-125b | interferon-stimulated genes | COVID-19 | Viral replication↓ | [214] |
| angiopoietin-1, HGF | None reported | COVID-19 | Alveolar regeneration↑, angiogenesis↑, and cell survival↑, lung repair↑ | [214,215] |
| miR-146a-5p, miR-451 | TRAF6, TLR4/NF-κB, MIF-PI3K-AKT | ALI | M2 polarization↑ | [217–219] |
| miR-199a-5p | CAV1/NRF2/HO-1 | ALI | Oxidative stress↓ | [220] |
| None reported | SLC7A11, GPX4, NRF2 | ALI | Lung epithelial cells↑ | [221,222] |
| miR-199b-5p | AFTPH, NF-κB | ALI | Inflammatory response↓ | [226] |
| miR-486-5p | SMAD2, Akt | Radiation-induced lung injury | Fibrosis↓, epithelial regeneration↑ | [222] |
| miR-377-3p | RPTOR | ALI | Autophagy↑ | [227] |
| miR-451 | TSC1/mTOR | ALI | Macrophage autophagy↓ | [228] |
| None reported | NF-κB | COPD | Inflammation↓ | [233] |
| None reported | MMP-9, TIMP-1 | COPD | Alveolar destruction↓ | [233] |
| miR-146a-5p, miR-10a-5p | VEGF-VEGFR2, AKT, MEK/ERK | COPD | Endothelial apoptosis↓, endothelial proliferation↑, gas exchange↑ | [234] |
| None reported | TRAF1/ NF-κB, PI3K/AKT | Asthma | M2 polarization↑, neutrophil infiltration↓ | [235] |
| miR-146a-5p | None reported | Asthma | IL-13↓, eosinophil recruitment↓ | [236] |
| CAV-1 | STAT6 | Asthma | Airway epithelial integrity↑ | [238] |
| None reported | TGF-β1/Smad2/3 | Asthma | Goblet cell metaplasia↓, subepithelial collagen deposition↓, α-SMA-driven fibrosis↓ | [239] |
| miR-146a-5p | TRAF6, IRAK1, NF-κB/NLRP3 | asthma | Inflammation↓, epithelial barrier disruption↓ | [240] |
| miR-148a-3p | Hsp90b1 | Silicosis | Collagen synthesis↓, fibroblast activation↓ | [241] |
| let-7i-5p | TGFBR1, TGF-β1/Smad3 | Silicosis | ECM deposition↓ | [242] |
| miR-223-3p | PWWP2A/NLRP3 | Silicosis | Inflammation↓ | [243] |
| miR-26a-5p | Notch | Silicosis | EMT↓ | [244] |
| TGF-β1 siRNA | Smad2/3, Akt/GSK-3β/β-catenin, MAPK, and NF-κB | Lung cancer | EMT↓, migration↓, invasion↓ | [248] |
| miR-320a | SOX4, Wnt/β-catenin | Lung cancer | Proliferation↓, metastasis↓ | [249] |
| miR-410 | PTEN | lung cancer | proliferation↑, apoptosis↓ | [247] |
Notes: a ↑ indicates promotion or upregulation; ↓ indicates inhibition or downregulation.